[Comparative observation on electroacupuncture combined with acupoint-injection for treatment of oculomotor paralysis induced by aneurysm of cerebral posterior communicating artery].
OBJECTIVE
To compare clinical therapeutic effects of electroacupuncture (EA) combined with acupoint-injection and simple acupuncture on oculomotor paralysis induced by aneurysm of cerebral posterior communicating artery.


METHODS
Seventy-eight cases were randomly divided into an acupuncture group and an EA plus acupoint-injection group. In the acupuncture group, Jingming (BL 1), Qiuhou (EX-HN 7), Chengqi (ST 1), etc., were selected and the EA plus acupoint-injection group were treated by the same method as in the acupuncture group, in combination with EA and local acupoint injection of adenosine cobaltamine. After treatment of 3 months, their therapeutic effects were compared.


RESULTS
The total effective rate was 41.7% in the acupuncture group and 77.8% in the EA plus acupoint-injection group, with a very significant difference between the two groups (P<0.01). The therapeutic effect in the patients who received the operation within 2 weeks after attack was better than that in those who received the operation over 2 weeks after attack (P<0.01); the therapeutic effect in the patients who received acupuncture treatment within 1 month after the operation was better than that over 1 month after the operation(P<0.01).


CONCLUSIONS
EA plus acupoint-injection is an effective method for oculomotor paralysis induced by aneurysm of cerebral posterior communicating artery, with a better therapeutic effect than that of simple acupuncture, and early diagnosis, surgery and timely acupuncture treatment are closely related with its prognosis.
Zhang
Xiao-zhe
XZ
Acupuncture Section, Pain Relieving Center, Beijing Tiantan Hospital, Beijing, China. zhang-xiaozhe@hotmail.com
D015669:Acupuncture Points; D000328:Adult; D015671:Electroacupuncture / Q000379:methods*; D005260:Female; D006801:Humans; D007267:Injections; D002532:Intracranial Aneurysm / Q000150:complications*; D008297:Male; D008875:Middle Aged; D009886:Ophthalmoplegia / Q000209:etiology / Q000628:therapy*